BioXcel Therapeutics, Inc.
NASDAQ:BTAI
0.3511 (USD) • At close December 24, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|
| Assets: | ||||||||
| Current Assets: | ||||||||
| Cash & Cash Equivalents
| 65.221 | 193.725 | 232.968 | 213.119 | 32.426 | 42.565 | 0.887 | 0 |
| Short Term Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash and Short Term Investments
| 65.221 | 193.725 | 232.968 | 213.119 | 32.426 | 42.565 | 0.887 | 0 |
| Net Receivables
| 0.071 | 0.248 | 0 | 0 | 0 | 0.115 | 0 | 0 |
| Inventory
| 1.991 | 1.985 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets
| 4.86 | 6.91 | 3.844 | 6.908 | 1.681 | 0.491 | 0.003 | 0.002 |
| Total Current Assets
| 72.143 | 202.868 | 232.968 | 217.065 | 34.107 | 43.171 | 0.89 | 0.002 |
| Non-Current Assets: | ||||||||
| Property, Plant & Equipment, Net
| 1.472 | 2.06 | 2.541 | 2.784 | 2.234 | 0.327 | 0.004 | 0.005 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill and Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets
| 0.087 | 0.925 | 3.93 | 0.087 | 0.051 | 0.051 | 0.461 | 0 |
| Total Non-Current Assets
| 1.559 | 2.985 | 6.471 | 2.871 | 2.285 | 0.378 | 0.465 | 0.005 |
| Total Assets
| 73.702 | 205.853 | 239.439 | 219.936 | 36.392 | 43.549 | 1.355 | 0.007 |
| Liabilities & Equity: | ||||||||
| Current Liabilities: | ||||||||
| Account Payables
| 13.654 | 10.228 | 4.678 | 3.979 | 4.953 | 1.604 | 0.444 | 0.279 |
| Short Term Debt
| 0.346 | 0.319 | 0.293 | 0.237 | 0 | 0 | 0.371 | 0 |
| Tax Payables
| 0.116 | 0.082 | 0.302 | 0.697 | 0 | 0 | 0 | 0 |
| Deferred Revenue
| 0 | 0 | 0 | 7.389 | -0.164 | 0 | 0 | 0 |
| Other Current Liabilities
| 13.151 | 22.269 | 11.394 | 6.929 | 3.515 | 3.056 | 1.522 | 0.052 |
| Total Current Liabilities
| 27.267 | 32.898 | 16.667 | 11.842 | 8.468 | 4.66 | 2.337 | 0.331 |
| Non-Current Liabilities: | ||||||||
| Long Term Debt
| 101.038 | 94.623 | 2.21 | 2.796 | 1.029 | 0 | 0 | 0 |
| Deferred Revenue Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 1.905 | 1.557 | -1.105 | -1.398 | 0 | 0 | 0 | 0 |
| Total Non-Current Liabilities
| 102.943 | 96.18 | 1.105 | 1.398 | 1.029 | 0 | 0 | 0 |
| Total Liabilities
| 130.21 | 129.078 | 17.772 | 13.24 | 9.497 | 4.66 | 2.337 | 0.331 |
| Equity: | ||||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock
| 0.03 | 0.028 | 0.028 | 0.024 | 0.018 | 0.016 | 0.01 | 0 |
| Retained Earnings
| -590.598 | -411.545 | -245.788 | -138.857 | -56.688 | -23.72 | -4.45 | 0 |
| Accumulated Other Comprehensive Income/Loss
| 0 | 0 | 0 | 0 | 0 | -0.018 | -0.001 | 0 |
| Other Total Stockholders Equity
| 534.06 | 488.292 | 467.427 | 345.529 | 83.565 | 62.593 | 3.459 | -0.324 |
| Total Shareholders Equity
| -56.508 | 76.775 | 221.667 | 206.696 | 26.895 | 38.889 | -0.982 | -0.324 |
| Total Equity
| -56.508 | 76.775 | 221.667 | 206.696 | 26.895 | 38.889 | -0.982 | -0.324 |
| Total Liabilities & Shareholders Equity
| 73.702 | 205.853 | 239.439 | 219.936 | 36.392 | 43.549 | 1.355 | 0.007 |